29
Views
15
CrossRef citations to date
0
Altmetric
Research Article

The safety and efficacy of zotepine in the treatment of schizophrenia: Results of a one-year naturalistic clinical trial

, , , , , , & show all
Pages 299-306 | Published online: 12 Jul 2009

  • Regier DA, Narrow WE, Rae DS et al (1993) The de facto US Mental and Addictive Disorders System: epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry 50: 85-94.
  • National Health Service Executive (1996) Burdens of disease discussion paper. National Health Service Executive, Leeds.
  • Knapp M, Kavanagh S (1997) Economic outcomes and costs in the treatment of schizophrenia. Clin Therapeutics 19: 128-38.
  • Weiden PJ, Olfson M (1995) Cost of relapse in schizophrenia. Schizophrenia Bull 21: 419-29.
  • Tollefson GD, Beasley CM, Tran PV et al (1997) Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry 154: 457-65.
  • Kane JM (1987) Treatment of schizophrenia Schizophr Bull 13: 133-56.
  • Hummer M, Fleischhacker WW (1996) Compliance and outcome in patients treated with antipsychotics: the impact of extrapyramidal symptoms. CNS Drugs 5 (suppl 1): 13-20.
  • Needham PL, Atkinson J, Skill MJ, Heal DJ (1996) Zotepine: Preclinical tests predict antipsychotic efficacy and an atypical profile. Psychopharmacol Bull 31: 123-8.
  • Roth BL, Craigo SC, Choudray MS et al (1994) Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 268: 1403-9.
  • Leysen JE, Janssen PMF, Schotte A et al (1993) Interaction of antipsychotic drugs with neurotransmitter sites in vitro and in vivo in relation to pharmacological and clinical effects: Role of 5HT2 receptors. Psychopharmacobgy 112: S40-S54.
  • Leysen JE, Janssen PMF, Heylen L et al (1998) Receptor interactions of new antipsychotics: relation to pharmacodynamics and clinical effects. Int J Psychiatr Clin Pract 2 (suppl 2): S3-S17.
  • Rowley HL, Kilpatrick IC, Needham PL, Heal DJ (1998) Elevation of extracellular cortical noradrenaline may contribute to the antidepressant activity of zotepine: an in vivo microdialysis study in freely-moving rats. Neuropharmacol 37: 937-44.
  • Petit M, Raniwalla J, Tweed J et al (1996) A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallelgroup double-blind trial Psychopharmacol Bull 32: 81-7.
  • Cooper SJ (1996) Abstract presented at 20th Collegium Internationale Neuropsychopharmacologicum (CINP), Melbourne, Australia, June 23-27.
  • Barnas C, Stuppäck C, Miller C et al (1992) Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. haloperidol. Int Clin Psychopharmacol 7: 23-7.
  • Cooper SJ, Butler A, Tweed J, Welch C, Raniwalla J. (2000) Zoterpine in the Prevention of Recurrence: A randomised, double blind placebo-controlled study for chronic schizophrenia. Psychopharmacology 150: 237-43.
  • American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn) (DSM-III-R). APA, Washington, DC.
  • Overall JE, Gorham DH (1988) Introduction -- The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol Bull 24: 97-9.
  • Andreasen NC (1989) The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundation. Br J Psychiatry 155 (Suppl. 7): 49-58.
  • Guy W (1976) ECDEU Assessment Manual for Psychopharmacology, revised DHEW Pub. No. (ADM) 76 338. pp. 218-22. Rockville, MD: National Institute of Mental Health.
  • Guy W, ECDEU Assessment Manual for Psychopharmacology. Rev. Ed. DHEW Pub. No. (ADM) 76338 Rockville, MD: National Institute of Mental Health, pp. 534-7.
  • Simpson GM Angus JSW (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 45 (suppl 212): 11-19.
  • Barnes TRE (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154: 672-76.
  • Hollander M, Wolfe DA (1973) Nonparametric statistical methods (pp. 33-8). New York Wiley.
  • Fleischhacker W, Barnas C, Stuppäck CH et al (1989) Zotepine vs haloperidol in paranoid schizophrenia. Psychopharmacol Bull 25: 97-100.
  • Dieterle DM Müller-Spahn F, Ackenheil M (1991) Efficacy and tolerance of zotepine in a double-blind comparison with perazine in schizophrenics. Fortschr Neural Psychiatr 59 (suppl. 1): 18-22.
  • Müller-Spahn F, Dieterle DM, Ackenheil M (1991) Clinical efficacy of zotepine in the treatment of schizophrenic negative systems. Fortschr Neural Psychiatr 59 (suppl. 1): 30-5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.